search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


The impact of thinking and doing on chlamydia transmission (iMPaCT)


- candidate number25523
- NTR NumberNTR6307
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR11-nov-2016
- Secondary IDsNL57481.094.16 METC Noord-Holland
- Public TitleThe impact of thinking and doing on chlamydia transmission (iMPaCT)
- Scientific TitleMathematical models incorporating Psychological determinants: control of Chlamydia Transmission (iMPaCT)
- ACRONYMiMPaCT
- hypothesisWe aim to study the link between behavioural and psychological determinants and chlamydia (re-)infection, and to develop mathematical models for curable STI incorporating these determinants to be able to better estimate the impact of interventions.
- Healt Condition(s) or Problem(s) studiedChlamydia trachomatis
- Inclusion criteria- Being a heterosexual man or woman
- Between 18 and 24 years old
- Not notified by partner
- Exclusion criteria- Not living in the Netherlands
- Inability to read or speak Dutch
- Men who have sex with men (MSM), women who have sex with women (WSW) and men/women who have sex with both men and women
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlNot applicable
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 8-nov-2016
- planned closingdate1-jul-2018
- Target number of participants2000
- InterventionsThe aim of this observational study is to collect data on sexual behaviour and psychological determinants from people visiting STI clinics. Participants are enrolled for a year, and questionnaires are administrated at four time points: at baseline, 3-4 weeks, 6 months and at one year follow-up. To be able to link behavioural and psychological determinants to (re-)infections, participants will be tested for chlamydia at enrolment and at 6 months follow-up.
- Primary outcomeThe main parameters of the study are chlamydia (re-)infection and demographic, behavioural and psychological determinants.
- Secondary outcomeNot applicable
- TimepointsFour time points:
1. Baseline
2. 1 month follow-up
3. 6-months follow-up
4. 1 year follow-up
- Trial web sitewww.rivm.nl/impact
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIES D.A. van Wees
- CONTACT for SCIENTIFIC QUERIES D.A. van Wees
- Sponsor/Initiator Strategisch Programma RIVM (SPR)
- Funding
(Source(s) of Monetary or Material Support)
National Institute of Public Health and Environmental Protection (RIVM), Epidemiology and Surveillance (EPI), Centre for Infectious Disease Control (CIB)
- Publications
- Brief summaryChlamydia is the most commonly reported STI in the Netherlands and the number of reported cases has been increasing in the past few years. Control of this infection is of public health importance, because chlamydia infections are associated with increased risk of serious reproductive consequences, such as pelvic inflammatory disease (PID), ectopic pregnancy and infertility. However, control of chlamydia has proven to be challenging; reasons for this might be high re-infection rates after treatment. Therefore, behaviour change after a diagnosis might be vital to reduce re-infection rates. In addition, because most people are unaware of their infection, preventive health actions (such as using condoms) depend on psychological determinants, making the incorporation of such determinants in mathematical models especially important in this field. Ultimately, the data collected in the clinical study will be used to parameterise a mathematical model, which will provide valuable information for public health policy makers to guide which intervention measures should be prioritised and conducted in the future.
- Main changes (audit trail)
- RECORD11-nov-2016 - 24-mei-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl